ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
MISGAV, Israel, May 6, 2024 /PRNewswire/ — ZygoFix Ltd. a portfolio company of The Trendlines Group Ltd. (“Trendlines”) announced that it received regulatory clearance from the United States Food and Drug Administration (FDA clearance) for its zLOCK Lumbar Facet Fixation System. This achievement was supported by compelling clinical evidence from the company’s ongoing European clinical study, marking a significant advancement in spinal fusion technology.
Related news for (TRNLY)
- Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair
- Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases
- Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases
- Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment